modotuximab
Showing 1 - 4 of 4
Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)
Recruiting
- Metastatic Colorectal Cancer
- Futuximab/modotuximab
- Trifluridine/Tipiracil
-
Ann Arbor, Michigan
- +10 more
Dec 2, 2022
Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial in Worldwide (Sym004, Futuximab, Modotuximab)
Terminated
- Metastatic Colorectal Cancer
- +2 more
- Sym004
- +2 more
-
Duarte, California
- +17 more
Sep 7, 2020
Metastatic Colorectal Cancer Trial in Worldwide (Sym004 (12 mg/kg), Sym004 (9/6 mg/kg), Best Supportive Care (BSC))
Completed
- Metastatic Colorectal Cancer
- Sym004 (12 mg/kg)
- +4 more
-
Los Angeles, California
- +53 more
Apr 9, 2019